VOYA Investment Management
ATNM icon

VOYA Investment Management’s Actinium Pharmaceuticals ATNM Stock Holding History

VOYA Investment Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,633
Closed -$78.7K – 2811
2024
Q2 		$78.7K Buy
10,633
+463
+5% +$3.81K ﹤0.01% 2729
2024
Q1 		$79.6K Sell
10,170
-844
-8% -$5.43K ﹤0.01% 2661
2023
Q4 		$56K Hold
11,014
– – ﹤0.01% 2838
2023
Q3 		$65.2K Hold
11,014
– – ﹤0.01% 2823
2023
Q2 		$81.7K Buy
+11,014
New +$93.7K ﹤0.01% 2838

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

VOYA Investment Management's ATNM Position: Q3 2024 in Review

VOYA Investment Management sold out of Actinium Pharmaceuticals (ATNM) in Q3 2024, closing a stake of 10,633 shares — an estimated $78.7K sold.

VOYA Investment Management first reported a position in ATNM in Q2 2023 and held it in 5 quarters. The position peaked at $81.7K in Q2 2023. 72 funds tracked by Wall St. Rank hold ATNM as of Q3 2024.

  • VOYA Investment Management reported no remaining Actinium Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • VOYA Investment Management sold 10,633 Actinium Pharmaceuticals shares in Q3 2024, an estimated $78.7K.
  • VOYA Investment Management first reported a position in Actinium Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • VOYA Investment Management's Actinium Pharmaceuticals position peaked at $81.7K in Q2 2023.
  • 72 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2024.

Based on VOYA Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.